Optimizing the Development Strategy of Combination Therapy in Respiratory Medicine: From Isolated Airways to Patients

The current recommendations for the treatment of chronic obstructive pulmonary disease (COPD) are pushing towards triple combination therapy based on the combination of an inhaled corticosteroid (ICS) associated with two bronchodilator agents. However, dual bronchodilation remains the cornerstone fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Calzetta, Luigino, Matera, Maria Gabriella, Cazzola, Mario, Rogliani, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860506/
https://www.ncbi.nlm.nih.gov/pubmed/31654332
http://dx.doi.org/10.1007/s12325-019-01119-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6860506/
https://www.ncbi.nlm.nih.gov/pubmed/31654332
http://dx.doi.org/10.1007/s12325-019-01119-w

Ejemplares similares